These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 20199367
1. Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney-transplant patients. Puissant-Lubrano B, Rostaing L, Kamar N, Abbal M, Fort M, Blancher A. Exp Clin Transplant; 2010 Mar; 8(1):19-28. PubMed ID: 20199367 [Abstract] [Full Text] [Related]
2. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H, Otte B, Lang D, Heidenreich S. Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [Abstract] [Full Text] [Related]
3. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Bingham CO, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, Trzaskoma B, Martin F, Agarwal S, Kelman A. Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397 [Abstract] [Full Text] [Related]
4. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab. Alausa M, Almagro U, Siddiqi N, Zuiderweg R, Medipalli R, Hariharan S. Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147 [Abstract] [Full Text] [Related]
5. Effectiveness of rituximab and intravenous immunoglobulin therapy in renal transplant recipients with chronic active antibody-mediated rejection. Hong YA, Kim HG, Choi SR, Sun IO, Park HS, Chung BH, Choi BS, Park CW, Kim YS, Yang CW. Transplant Proc; 2012 Jan; 44(1):182-4. PubMed ID: 22310610 [Abstract] [Full Text] [Related]
6. Impaired cellular immune response to diphtheria and tetanus vaccines in children after thoracic transplantation. Urschel S, Rieck BD, Birnbaum J, Dalla Pozza R, Rieber N, Januszewska K, Fuchs A, West LJ, Netz H, Belohradsky BH. Pediatr Transplant; 2011 May; 15(3):272-80. PubMed ID: 21272167 [Abstract] [Full Text] [Related]
10. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab? Buser A, Stern M, Arber C, Medinger M, Halter J, Rovo A, Favre G, Lohri A, Tichelli A, Gratwohl A. Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668 [Abstract] [Full Text] [Related]
11. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92. Calaminus G, Hense B, Laws HJ, Groeger M, MacKenzie CR, Göbel U. Klin Padiatr; 2007 Oct; 219(6):355-60. PubMed ID: 18050047 [Abstract] [Full Text] [Related]
12. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB. Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959 [Abstract] [Full Text] [Related]
13. Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. McCusker C, Somerville W, Grey V, Mazer B. Ann Allergy Asthma Immunol; 1997 Aug; 79(2):145-50. PubMed ID: 9291419 [Abstract] [Full Text] [Related]
16. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Calvo-Turrubiartes M, Romano-Moreno S, García-Hernández M, Chevaile-Ramos JA, Layseca-Espinosa E, González-Amaro R, Portales-Pérez D. Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271 [Abstract] [Full Text] [Related]